Pro-inflammatory mediators such as IL-6 and IL-8 could be released in the presence of cigarette smoke extract (CSE), and treatment with a specific AMPK activator could significantly reduce pro-inflammatory cytokine release, implying that AMPK activation is helpful to inhibit the development of COPD inflammation [33]. Here, CXCL8 is linked to chronic obstructive pulmonary disease.